ОПЫТ ЛЕЧЕНИЯ БОЛЬНЫХ НЕАЛКОГОЛЬНЫМ СТЕАТОГЕПАТИТОМ (НАСГ) ПОЛИЕНИЛФОСФАТИДИЛХОЛИНОМ

Conducted non-invasive assessment of index of liver fibrosis (IF) and clinical efficacy of polyenylphosphatidylcholine in the treatment of 30 patients NASH within 3-6 months. Monotherapy with this drug in a dose of 2 capsules 3 times a day resulted in a significant reduction of IF, indicators of cytolysis and cholestasis in 3 months. In 33.3% of cases there was a clear positive dynamics ultrasound picture of the liver. In 10 patients with insignificant dynamics of biochemical parameters the treatment was continued up to 6 months, after which liver function tests normalized. Treatment of patients with Nash polyenylphosphatidylcholine is effective, the treatment time should be between 3 to 6 months.